Parkinson's Disease Symposium

Saturday, Octoberr 10, 2020

Virtual Meeting
8:30 am - 5:30 pm
CO-CHAIRS: Suketu Khandhar MD & James Tetrud MD


courtesy of pixabay

Parkinson's disease is a progressive neuro-degenerative disorder that affects up to 1 million Americans. It is the second most common neuro-degenerative disorder after Alzheimer's disease. Currently effective symptomatic treatment options exist but are not consistently practiced leading to variability in care for this patient population. The understanding and treatment of Parkinson’s disease is ever expanding affording our patients more opportunities and options for a better quality of life. SFNS will hold its FOURTH biennial Parkinson's disease Symposium in October 2020. Our last PD symposium was highly successful, attracting clinicians of all fields who participate in the care of patients with Parkinson's disease. Topics presented will include the Prodrome of PD, Thinking outside Dopamine, Targeting Alpha-Synuclein, Sleep in PD, TeleHealth and the Physiology of Tremors.

Educational Objectives

1. Identify the scope of telehealth in the care delivery of Parkinson’s disease to improve access to care.

2. Recognize the role of non-dopaminergic medical therapies in Parkinson's disease which can expand the scope of care for this population.

3. Identify and distinguish symptoms of various tremor disorders.

4. Describe associated symptoms that can result from Parkinson’s disease, including sleep issues and prodromal symptoms allowing for possible early detection.

Accreditation Statement:

This San Francisco Neurological Society is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. The San Francisco Neurological Society takes responsibility for the content, quality and scientific integrity of this CME activity.

Designation Statement:

The San Francisco Neurological Society designates this educational activity for an estimated 7.0 AMA PRA Category 1 Credit(s) TM . This credit may also be applied to the CMA Certification in Continuing Medical Education.

Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit(s) TM issued by organizations accredited by the ACCME.

Who Should Attend:

Neurologists, neurosurgeons, neuroradiologists, neuropsychologists, residents, nurses, nurse practioners, neuropediatricians and allied health professionals.

Registration Fees:

(Early Bird Registration discount by October 1, 2020)

SFNS Members (Active/Associate/Retired):
Full-Day Program: $200
After October 1st: $225

Non-Members:
Full-Day Program: $225
After October 1st: $250

Students, Residents and Fellows:
Full-Day Program: FREE

Nurses:
Full-Day Program: $150
After October 1st: $175

Industry (non-exhibitor):
Full-Day Program: $500
After October 1st: $500

CANCELLATION POLICY: If you have preregistered but must cancel, refunds may be issued with 72 hours advance notice, minus a $25 handling fee.

Program Agenda: